These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 36848776)

  • 21. [Recent advances in the structural biology of the class C G protein-coupled receptors: The metabotropic Glutamate receptor 5].
    Berto L; Dumazer A; Malhaire F; Cannone G; Kutti Ragunath V; Goudet C; Lebon G
    Biol Aujourdhui; 2021; 215(3-4):85-94. PubMed ID: 35275053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bitopic Ligands and Metastable Binding Sites: Opportunities for G Protein-Coupled Receptor (GPCR) Medicinal Chemistry.
    Fronik P; Gaiser BI; Sejer Pedersen D
    J Med Chem; 2017 May; 60(10):4126-4134. PubMed ID: 28140580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential for the Rational Design of Allosteric Modulators of Class C GPCRs.
    Christopher JA; Doré AS; Tehan BG
    Curr Top Med Chem; 2017; 17(1):71-78. PubMed ID: 27448651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging paradigms in GPCR allostery: implications for drug discovery.
    Wootten D; Christopoulos A; Sexton PM
    Nat Rev Drug Discov; 2013 Aug; 12(8):630-44. PubMed ID: 23903222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs.
    Bartuzi D; Kaczor AA; Matosiuk D
    Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deep Learning Dynamic Allostery of G-Protein-Coupled Receptors.
    Do H; Wang J; Miao Y
    Res Sq; 2023 Feb; ():. PubMed ID: 36865316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deep Learning Dynamic Allostery of G-Protein-Coupled Receptors.
    Do HN; Wang J; Miao Y
    bioRxiv; 2023 Feb; ():. PubMed ID: 36711515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GPCR Allostery: A View from Computational Biology.
    Li M; Bao Y; Li M; Guo J
    Curr Med Chem; 2023; 30(40):4533-4553. PubMed ID: 36642879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of tractable allosteric sites in G protein-coupled receptors.
    Wakefield AE; Mason JS; Vajda S; Keserű GM
    Sci Rep; 2019 Apr; 9(1):6180. PubMed ID: 30992500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Insights into the Structure and Function of Class B1 GPCRs.
    Cary BP; Zhang X; Cao J; Johnson RM; Piper SJ; Gerrard EJ; Wootten D; Sexton PM
    Endocr Rev; 2023 May; 44(3):492-517. PubMed ID: 36546772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of Mixed-Solvent Molecular Dynamics Simulations for Prediction of Allosteric Sites on G Protein-Coupled Receptors.
    Chan WKB; Carlson HA; Traynor JR
    Mol Pharmacol; 2023 May; 103(5):274-285. PubMed ID: 36868791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cryo-Electron Microscopy: Moving Beyond X-Ray Crystal Structures for Drug Receptors and Drug Development.
    García-Nafría J; Tate CG
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():51-71. PubMed ID: 31348870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological hallmarks of allostery at the M4 muscarinic receptor elucidated through structure and dynamics.
    Vuckovic Z; Wang J; Pham V; Mobbs JI; Belousoff MJ; Bhattarai A; Burger WAC; Thompson G; Yeasmin M; Nawaratne V; Leach K; van der Westhuizen ET; Khajehali E; Liang YL; Glukhova A; Wootten D; Lindsley CW; Tobin A; Sexton P; Danev R; Valant C; Miao Y; Christopoulos A; Thal DM
    Elife; 2023 May; 12():. PubMed ID: 37248726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allosteric modulation of G protein-coupled receptors.
    May LT; Avlani VA; Sexton PM; Christopoulos A
    Curr Pharm Des; 2004; 10(17):2003-13. PubMed ID: 15279541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery.
    Zhang M; Chen T; Lu X; Lan X; Chen Z; Lu S
    Signal Transduct Target Ther; 2024 Apr; 9(1):88. PubMed ID: 38594257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures.
    Shimada I; Ueda T; Kofuku Y; Eddy MT; Wüthrich K
    Nat Rev Drug Discov; 2019 Jan; 18(1):59-82. PubMed ID: 30410121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors.
    Feng Z; Hu G; Ma S; Xie XQ
    AAPS J; 2015 Sep; 17(5):1080-95. PubMed ID: 25940084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Class B1 GPCR activation by an intracellular agonist.
    Kobayashi K; Kawakami K; Kusakizako T; Tomita A; Nishimura M; Sawada K; Okamoto HH; Hiratsuka S; Nakamura G; Kuwabara R; Noda H; Muramatsu H; Shimizu M; Taguchi T; Inoue A; Murata T; Nureki O
    Nature; 2023 Jun; 618(7967):1085-1093. PubMed ID: 37286611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endogenous allosteric modulators of G protein-coupled receptors.
    van der Westhuizen ET; Valant C; Sexton PM; Christopoulos A
    J Pharmacol Exp Ther; 2015 May; 353(2):246-60. PubMed ID: 25650376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current and Future Challenges in GPCR Drug Discovery.
    Topiol S
    Methods Mol Biol; 2018; 1705():1-21. PubMed ID: 29188556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.